Contract notice
Section I: Contracting
authority
I.1) Name and addresses
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: michelle.clarke@dh.gsi.gov.uk
NUTS: UK
Internet address(es)
Main address: https://cmu.bravosolution.co.uk
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://cmu.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://cmu.bravosolution.co.uk
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://cmu.bravosolution.co.uk
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHS framework agreement for Hepatitis C medicines for Midlands and East and North of England regions.
Reference number: CM/PHR/16/5529
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
NHS framework agreement for Hepatitis C medicines for Midlands and East and North of England regions.
Period of framework agreement: 1.3.2017 — 28.2.2018 with an option to extend for up to 12 months.
II.1.5) Estimated total value
Value excluding VAT:
180 000 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for all lots
II.2) Description
Lot No: 1
II.2.1) Title
NHS Framework Agreement for Hepatitis C Medicines for Midlands and East
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKH
UKF
UKG
Main site or place of performance:
Please refer to Document 10 in the ITO documents for the list of purchasing points.
II.2.4) Description of the procurement
Products associated with the lots are listed on Document No. 06c of the Invitation to Offer. Each individual National Product Code (NPC) pack description in each of the regions (Midlands and East of England, North of England ) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
01/03/2017
End:
28/02/2019
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
Yes
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
NHS Framework Agreement for Hepatitis C medicines for North of England
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKD
UKE
UKC
Main site or place of performance:
Please refer to Document 10 in the ITO documents for the list of purchasing points.
II.2.4) Description of the procurement
Products associated with the lots are listed on Document No. 06c of the Invitation to Offer. Each individual National Product Code (NPC) pack description in each of the regions (Midlands and East of England, North of England) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
01/03/2017
End:
28/02/2019
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
Yes
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.3) Technical and professional ability
List and brief description of selection criteria:
Please refer to the award criteria contained in the Invitation To Offer.
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement with several operators.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
05/01/2017
Local time: 13:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.7) Conditions for opening of tenders
Date:
05/01/2017
Local time: 13:00
Place:
Runcorn.
Information about authorised persons and opening procedure:
Commercial Medicines Unit employee.
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3) Additional information
Any supplier may be disqualified who does not respond to the following in the requisite manner:
1) Submission of expression of interest and procurement specific information.
This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:
— accept the terms and conditions and click continue,
— enter your correct business and user details,
— note the user name you chose and click ‘Save’ when complete,
— you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
a. login to the eTendering portal;
b. select ‘Response to ITT’;
c. select ‘ITTs Open To All Suppliers’;
d. access listing related to this procurement NHS framework agreement for Hepatitis C medicines for Midlands and East and North of England regions and view details;
e. click on ‘Express interest’ button at the top of the page;
f. once you have expressed interest, the ITT will move to ‘My ITTs’, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the ‘Publish’ button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 368 4850 or help@bravosolution.co.uk
The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
VI.4) Procedures for review
VI.4.1) Review body
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
Runcorn
UK
VI.5) Date of dispatch of this notice
23/11/2016